Penumbra Total Assets 2014-2024 | PEN
Penumbra total assets from 2014 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
- Penumbra total assets for the quarter ending September 30, 2024 were $1.479B, a 0.73% increase year-over-year.
- Penumbra total assets for 2023 were $1.556B, a 13.53% increase from 2022.
- Penumbra total assets for 2022 were $1.371B, a 10.18% increase from 2021.
- Penumbra total assets for 2021 were $1.244B, a 51.19% increase from 2020.
| Penumbra Annual Total Assets (Millions of US $) |
|
|---|---|
| 2023 | $1,556 |
| 2022 | $1,371 |
| 2021 | $1,244 |
| 2020 | $823 |
| 2019 | $666 |
| 2018 | $515 |
| 2017 | $477 |
| 2016 | $308 |
| 2015 | $264 |
| 2014 | $121 |
| 2013 | $71 |
| Penumbra Quarterly Total Assets (Millions of US $) |
|
|---|---|
| 2024-09-30 | $1,479 |
| 2024-06-30 | $1,535 |
| 2024-03-31 | $1,580 |
| 2023-12-31 | $1,556 |
| 2023-09-30 | $1,468 |
| 2023-06-30 | $1,433 |
| 2023-03-31 | $1,395 |
| 2022-12-31 | $1,371 |
| 2022-09-30 | $1,322 |
| 2022-06-30 | $1,328 |
| 2022-03-31 | $1,302 |
| 2021-12-31 | $1,244 |
| 2021-09-30 | $973 |
| 2021-06-30 | $910 |
| 2021-03-31 | $841 |
| 2020-12-31 | $823 |
| 2020-09-30 | $810 |
| 2020-06-30 | $780 |
| 2020-03-31 | $664 |
| 2019-12-31 | $666 |
| 2019-09-30 | $614 |
| 2019-06-30 | $585 |
| 2019-03-31 | $569 |
| 2018-12-31 | $515 |
| 2018-09-30 | $501 |
| 2018-06-30 | $499 |
| 2018-03-31 | $490 |
| 2017-12-31 | $477 |
| 2017-09-30 | $459 |
| 2017-06-30 | $417 |
| 2017-03-31 | $418 |
| 2016-12-31 | $308 |
| 2016-09-30 | $297 |
| 2016-06-30 | $284 |
| 2016-03-31 | $275 |
| 2015-12-31 | $264 |
| 2015-09-30 | $259 |
| 2015-06-30 | $0 |
| 2015-03-31 | $0 |
| 2014-12-31 | $0 |
| 2014-09-30 | $0 |
| 2013-12-31 | $71 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $9.100B | $1.059B |
| Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $194.739B | 23.76 |
| Intuitive Surgical (ISRG) | United States | $191.917B | 100.34 |
| Alcon (ALC) | Switzerland | $42.138B | 28.19 |
| Edwards Lifesciences (EW) | United States | $41.404B | 26.29 |
| IQVIA Holdings (IQV) | United States | $34.726B | 19.13 |
| IDEXX Laboratories (IDXX) | United States | $34.092B | 40.15 |
| DexCom (DXCM) | United States | $29.248B | 44.05 |
| STERIS (STE) | Ireland | $20.926B | 24.09 |
| Waters (WAT) | United States | $20.468B | 30.26 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.297B | 0.00 |
| Hologic (HOLX) | United States | $18.250B | 19.26 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.969B | 13.31 |
| Sysmex ADR (SSMXY) | Japan | $12.688B | 39.79 |
| Globus Medical (GMED) | United States | $11.345B | 28.73 |
| Teleflex (TFX) | United States | $8.967B | 14.30 |
| Masimo (MASI) | United States | $8.754B | 42.36 |
| Glaukos (GKOS) | United States | $7.951B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $4.883B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.479B | 25.38 |
| Veracyte (VCYT) | United States | $3.034B | 91.05 |
| Inari Medical (NARI) | United States | $2.984B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.789B | 16.10 |
| TransMedics (TMDX) | United States | $2.783B | 88.21 |
| Nihon Kohden (NHNKY) | Japan | $2.293B | 17.42 |
| Elekta AB (EKTAY) | Sweden | $2.192B | 17.86 |
| Tandem Diabetes Care (TNDM) | United States | $1.830B | 0.00 |
| RxSight (RXST) | United States | $1.819B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.766B | 9.23 |
| Alphatec Holdings (ATEC) | United States | $1.357B | 0.00 |
| Artivion (AORT) | United States | $1.129B | 74.81 |
| OPKO Health (OPK) | United States | $1.106B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.048B | 0.00 |
| Paragon 28 (FNA) | United States | $0.879B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.818B | 13.91 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.716B | 0.00 |
| IRadimed (IRMD) | United States | $0.650B | 35.10 |
| OrthoPediatrics (KIDS) | United States | $0.589B | 0.00 |
| AxoGen (AXGN) | United States | $0.561B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.542B | 12.77 |
| SiBone (SIBN) | United States | $0.517B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.483B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.471B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.378B | 20.48 |
| Semler Scientific (SMLR) | United States | $0.337B | 22.60 |
| CVRx (CVRX) | United States | $0.326B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.317B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.303B | 0.00 |
| NeuroPace (NPCE) | United States | $0.274B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.273B | 0.00 |
| Inogen (INGN) | United States | $0.226B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.191B | 0.00 |
| Accuray (ARAY) | United States | $0.185B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.161B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.160B | 0.00 |
| Nevro (NVRO) | United States | $0.159B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.152B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.137B | 14.68 |
| Spectral Diagnostics (EDTXF) | Canada | $0.112B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.089B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.088B | 0.00 |
| LENSAR (LNSR) | United States | $0.087B | 0.00 |
| 908 Devices (MASS) | United States | $0.086B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.078B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.070B | 0.00 |
| InspireMD (NSPR) | Israel | $0.067B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.063B | 0.00 |
| Hyperfine (HYPR) | United States | $0.063B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.057B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.055B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.047B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.044B | 0.00 |
| Envoy Medical (COCH) | United States | $0.040B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.027B | 0.00 |
| Neuronetics (STIM) | United States | $0.023B | 0.00 |
| NexGel (NXGL) | United States | $0.022B | 0.00 |
| Spectral AI (MDAI) | United States | $0.021B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.016B | 0.00 | |
| Microbot Medical (MBOT) | United States | $0.016B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.016B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.015B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.012B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.010B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Tenon Medical (TNON) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |